G. De Sanctis
About
In The Last Decade
G. De Sanctis
25 papers receiving 361 citations
Peers
Comparison fields: 5 of 63
- Immunology 255
- Genetics 97
- Pathology and Forensic Medicine 80
- Epidemiology 48
- Molecular Biology 45
Countries citing papers authored by G. De Sanctis
This map shows the geographic impact of G. De Sanctis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. De Sanctis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. De Sanctis more than expected).
Fields of papers citing papers by G. De Sanctis
This network shows the impact of papers produced by G. De Sanctis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. De Sanctis. The network helps show where G. De Sanctis may publish in the future.
Co-authorship network of co-authors of G. De Sanctis
This figure shows the co-authorship network connecting the top 25 collaborators of G. De Sanctis. A scholar is included among the top collaborators of G. De Sanctis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. De Sanctis. G. De Sanctis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 2 | |
| 3 | Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis. | 10 |
| 4 | 54 | |
| 5 | A randomized controlled trial of amantadine plus interferon alpha-2a vs interferon-alpha-2a in naive patients with chronic hepatitis C randomized based on early response to interferon alpha-2a alone. | 1 |
| 6 | 21 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 6 | |
| 11 | 21 | |
| 12 | 8 | |
| 13 | 3 | |
| 14 | 19 | |
| 15 | 7 | |
| 16 | 0 | |
| 17 | 7 | |
| 18 | 32 | |
| 19 | 7 | |
| 20 | 70 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.